Search - tctmd.com

Displaying 341 - 360 of 628

Sort: Relevancy | Date

News Conference News TCT 2017

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Michael O'Riordan

October 30, 2017

Presentation TCT 2017

Case Resolution: A High-Risk Patient With Complex Mutlivessel Disease How We Treated

Presenter: Issam D. Moussa, Emmanouil S. Brilakis

October 30, 2017

Presentation TCT 2017

PCI vs CABG in Multivessel Disease: What Do the US Guidelines and AUC Say?

Presenter: Issam D. Moussa, Manesh R. Patel

October 30, 2017

Presentation TCT 2017

PCI vs CABG in Multivessel Disease: What Do the Data and EU Guidelines Say?

Presenter: Issam D. Moussa, Alfredo R. Galassi

October 30, 2017

Presentation TCT 2017

South Africa Presents a Case: STEMI With Multivessel Disease

Presenter: Graham A. Cassel, Haim Danenberg, Giuseppe Tarantini, Riaz S Dawood

October 30, 2017

Presentation TCT 2017

Case Presentation: A High-Risk Patient With Complex Multivessel Disease PCI vs CABG?

Presenter: Issam D. Moussa, Emmanouil S. Brilakis

October 30, 2017

Presentation TCT 2017

Case Resolution: STEMI With Multivessel Disease How We Treated

Presenter: Sripal Bangalore, Anthony H. Gershlick, Prashant Kaul

October 30, 2017

Presentation TCT 2017

STEMI/ACS With Multivessel Disease: What Do the US Guidelines and AUC Say?

Presenter: Sripal Bangalore, Anthony H. Gershlick, Jacqueline E. Tamis-Holland

October 30, 2017

Presentation TCT 2017

STEMI/ACS With Multivessel Disease: What Do the Data and EU Guidelines Say?

Presenter: Sripal Bangalore, Anthony H. Gershlick, Stefan K. James

October 30, 2017

Presentation TCT 2017

Case Introduction: STEMI With Multivessel Disease How Should We Treat?

Presenter: Sripal Bangalore, Anthony H. Gershlick, Prashant Kaul

October 30, 2017

Presentation TCT 2017

Case #3: STEMI and Multivessel Disease (With Discussion)

Presenter: Timothy D. Henry, Thomas D. Stuckey, Dariusz Dudek

October 30, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day One

Shelley Wood

October 30, 2017

News Conference News TCT 2017

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

Todd Neale

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing COMPLETE Trial Change the Current Recommended Approach to Multivessel Disease in STEMI?

Presenter: C. Michael Gibson, Stephan Windecker, David Hildick-Smith

October 30, 2017

Presentation TCT 2017

Case #5: Primary PCI in a Patient With Multivessel Disease

Presenter: Jose L. Leiva-Pons, Ricardo Quizhpe

October 29, 2017

Presentation TCT 2017

PCI Is More Than a Valid Alternative for Most Cases in Left Main and Multivessel Disease

Presenter: Gary S. Mintz, Seung-Jung Park

October 29, 2017

Presentation TCT 2017

Case Presentation: A Patient With STEMI and Multivessel Disease

Presenter: Ran Kornowski, Mohamed Ahmed Sobhy, Owayed Al Shammeri

October 29, 2017

Presentation TCT 2017

Debate: STEMI With Multivessel Disease - Staged (Culprit) Lesion Revascularization Followed by Noninvasive Risk Stratification Is Currently Indicated

Presenter: Jeroen J. Bax, Michael A. Borger, Stephan Windecker, Giulio G. Stefanini

October 29, 2017

Presentation TCT 2017

Debate: STEMI With Multivessel Disease - Immediate (or Early) Routine Complete Revascularization Is the Way to Go

Presenter: Jeroen J. Bax, Michael A. Borger, Stephan Windecker, Anthony H. Gershlick

October 29, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

Advertisement

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Case Resolution: A High-Risk Patient With Complex Mutlivessel Disease How We Treated

PCI vs CABG in Multivessel Disease: What Do the US Guidelines and AUC Say?

PCI vs CABG in Multivessel Disease: What Do the Data and EU Guidelines Say?

South Africa Presents a Case: STEMI With Multivessel Disease

Case Presentation: A High-Risk Patient With Complex Multivessel Disease PCI vs CABG?

Case Resolution: STEMI With Multivessel Disease How We Treated

STEMI/ACS With Multivessel Disease: What Do the US Guidelines and AUC Say?

STEMI/ACS With Multivessel Disease: What Do the Data and EU Guidelines Say?

Case Introduction: STEMI With Multivessel Disease How Should We Treat?

Case #3: STEMI and Multivessel Disease (With Discussion)

Live From Denver: TCT 2017, Day One

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

Predicting the Future: Will the Ongoing COMPLETE Trial Change the Current Recommended Approach to Multivessel Disease in STEMI?

Case #5: Primary PCI in a Patient With Multivessel Disease

PCI Is More Than a Valid Alternative for Most Cases in Left Main and Multivessel Disease

Case Presentation: A Patient With STEMI and Multivessel Disease

Debate: STEMI With Multivessel Disease - Staged (Culprit) Lesion Revascularization Followed by Noninvasive Risk Stratification Is Currently Indicated

Debate: STEMI With Multivessel Disease - Immediate (or Early) Routine Complete Revascularization Is the Way to Go

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content